North America Ophthalmology Drugs and Devices Market, By Devices (Surgical Device, Diagnostics and Monitoring Devices, Vision care), Drug (Glaucoma Drugs, Retinal Disorder Drugs, Dry Eye Drugs, Allergic Conjunctivitis and Inflammation Drugs, Others), Delivery Type (Capsules and Tablets, Gels, Eye Drops, Eye Ointment, Eye Solutions), End Use (Hospitals, Diagnostic Centres, Others), Country (U.S., Mexico, Canada) Industry Trends and Forecast to 2029
Market Analysis and Insights : North America Ophthalmology Drugs and Devices Market
Data Bridge Market Research analyses that the North America ophthalmology drugs and devices market to be grow at a CAGR of 6.60% in the forecast period of 2022-2029 and is likely to reach the USD 51.64 billion by 2029.
The branch of medicine known as ophthalmology deals with the anatomy, body structure, and illnesses of the eyeball. An ophthalmologist is a doctor who specialises in the clinical and surgical treatment of eye problems. Ophthalmologists are both surgical and clinical experts because they perform operations on the eyes. The eye can detect a wide range of illnesses and ailments.
One of the major reasons likely to boost the growth and demand of the ophthalmology drugs and devices market is the rising prevalence of eye problems such as diabetic retinopathy and macular degeneration. The rise in the geriatric population and technological improvements in drug delivery techniques, are expected to propel the global ophthalmology drugs and devices market forward. Similarly, the increase in the prevalence of lifestyle related diseases such as obesity is expected to boost market growth. Furthermore, the rising incidences of eye organ diseases such as glaucoma and cataract and changing lifestyle are projected to contribute to the market's growth.
Moreover, increase in the investments for research and development activities and the presence of strong emerging pipeline drugs will create lucrative opportunities that will propel the ophthalmology drugs and devices market forward over the projection period.
However, high cost of devices and the dearth of health insurance in under-developed nations are expected to hinder the growth of the ophthalmology drugs and devices market. Also, patent expiration of blockbuster ophthalmic drugs and less awareness among population about eye diseases are just a few of the challenges that could stymie the ophthalmology drugs and devices market's growth.
This North America ophthalmology drugs and devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America ophthalmology drugs and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Ophthalmology Drugs and Devices Market Scope and Market Size
The North America ophthalmology drugs and devices market is segmented on the basis of devices, drug, delivery type and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on devices, market is segmented into surgical devices, diagnostics and monitoring devices and vision care. Diagnostic and monitoring devices are further sub-segmented into optical coherence tomography, ophthalmic ultrasound imaging systems, fundus camera market, ophthalmoscopes, retinoscope, pachymeter, wavefront aberrometers, perimeters/visual field analyzer, autorefractors/phoropter, specular microscope, corneal topographers and other. Surgical devices are further sub-segmented into cataract surgery devices, glaucoma surgery devices, refractive surgery devices and vitreoretinal surgery devices. Vision care is further sub-segmented into contact lens and spectacles.
- Ophthalmology drugs and devices market is segmented based on the drug into glaucoma drugs, retinal disorder drugs, dry eye drugs, allergic conjunctivitis and inflammation drugs and other drugs.
- On the basis of delivery type, ophthalmology drugs and devices market is segmented into capsules and tablets, gels, eye drops, eye ointment and eye solutions.
- On the basis of end-use, ophthalmology drugs and devices market is segmented into hospitals, diagnostic centres and others.
North America Ophthalmology Drugs and Devices Market Country Level Analysis
The North America ophthalmology drugs and devices market is analysed and market size insights and trends are provided by country, devices, drug, delivery type and end-use as referenced above.
The countries covered in the North America ophthalmology drugs and devices market report are U.S., Mexico, and Canada.
The country section of the North America ophthalmology drugs and devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The North America ophthalmology drugs and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America ophthalmology drugs and devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America ophthalmology drugs and devices market. The data is available for historic period 2010 to 2020.
Competitive Landscape and North America Ophthalmology Drugs and Devices Market Share Analysis
The North America ophthalmology drugs and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America ophthalmology drugs and devices market.
Some of the major players operating in the North America ophthalmology drugs and devices market are Johnson & Johnson Private Limited, Alcon Vision LLC, Ellex Medical, Bausch & Lomb Incorporated, ZEISS International, HOYA Corporation, Merck & Co., Inc., NIDEK CO., LTD, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd, TOPCON CORPORATION and Ziemer Ophthalmic Systems, among others.
SKU-